KC Animal Health Blog

<< Return to Blog List

Corridor Company Spotlight | Charles River Laboratories

by Emily McVey | Aug 05, 2019

Charles River Laboratories welcomed the exceptional team at Citoxlab, which also includes AccelLAB, Atlanbio, and SOLVO Biotechnology, into their family in April 2019. Charles River provides essential products and services to help both human and veterinary pharmaceutical, as well as biotechnology companies, government agencies, and leading academic institutions around the globe, accelerate their research and development efforts.

With over 16,000 global employees, Charles River is focused on providing you with exactly what you need to improve and expedite the discovery, early-stage development, and safe manufacture of your new veterinary therapies.

The addition of Citoxlab’s complementary service offerings and geographic footprint will enable Charles River to enhance the support they can provide for your early-stage research efforts.  In addition to the outstanding team at your local Stilwell, Kansas facility, you now have access to a wider network of talented scientists and market-leading scientific capabilities across the globe.  Citoxlab’s client-centric approach also solidifies Charles River’s foremost position in the outsourced safety assessment market at a time when we believe there is, and will continue to be, significant client demand for these outsourced services.

Citoxlab provides a broad suite of services that strengthens Charles River’s existing capabilities for the regulatory testing of veterinary pharmaceutical products in both domestic and livestock species, including:

Charles River is excited to get involved in the Kansas City community. Employees at the Stilwell facility will be able to participate in the activities of their local Corporate Social Responsibility program aimed at benefiting the communities where they live and work. Our employees are passionate about their role in improving the quality of people’s lives. Charles River’s mission, excellent science, and strong sense of purpose guides all that they do, and they approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.

The acquisition of Citoxlab further strengthens Charles River’s position as the leading, global, early-stage contract research organization by expanding its scientific portfolio and geographic footprint, which will enhance their ability to partner with clients across the drug discovery and development continuum.

To learn more about Charles River, visit our website at criver.com, or our scientific blog at eureka.criver.com.

Share

Search

Archive

News Releases

Media Coverage

Inside the Corridor

Investment Forum